Science Daily -
9 May 2016 23:26
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers--triple negative breast cancer.
Share this Article